Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Aafke A. Duizendstra"'
Autor:
Aafke A. Duizendstra, Michelle V. van der Grift, Patrick P. Boor, Lisanne Noordam, Robert J. de Knegt, Maikel P. Peppelenbosch, Michiel G. H. Betjes, Nicolle H. R. Litjens, Jaap Kwekkeboom
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
Spontaneous operational tolerance to the allograft develops in a proportion of liver transplant (LTx) recipients weaned off immunosuppressive drugs (IS). Several previous studies have investigated whether peripheral blood gene expression profiles cou
Externí odkaz:
https://doaj.org/article/e72d1e070ca04c0287a5515d0530bf10
Autor:
Aafke A, Duizendstra, Robert J, De Knegt, Nicole M A, Nagtzaam, Michiel G H, Betjes, Willem A, Dik, Nicolle H R, Litjens, Jaap, Kwekkeboom
Publikováno v:
Transplantation Proceedings, 54(7), 1874-1880. Elsevier Inc.
Background: Operationally tolerant liver transplant (LTx)-recipients can be weaned off immunosuppressive (IS) drugs without development of graft rejection. However, it is feared that liver fibrosis might develop after complete IS weaning. The purpose
Autor:
Michail Doukas, Robert A. de Man, Maikel P. Peppelenbosch, Dave Sprengers, Robert J. de Knegt, Dave L. Roelen, Patrick P.C. Boor, Michiel G. H. Betjes, Simone H. Brand-Schaaf, Jaap Kwekkeboom, Nicolle H.R. Litjens, Shanta Mancham, Mariska Klepper, Aafke A. Duizendstra
Publikováno v:
Liver Transplantation, 28(1), 98-112. WILEY
Liver Transplantation, 28(1), 98-112. John Wiley & Sons Ltd.
Liver Transplantation, 28(1), 98-112. John Wiley & Sons Ltd.
Spontaneous operational tolerance to the allograft develops in a proportion of liver transplantation (LT) recipients weaned off immunosuppressive (IS) drugs. Several studies have investigated whether peripheral blood circulating T cells could play a
Autor:
Herold J. Metselaar, Robert J. de Knegt, Jaap Kwekkeboom, Nicolle H.R. Litjens, Aafke A. Duizendstra, Robert A. de Man, Sarwa Darwish Murad, Sandra Coenen, Dave Sprengers, Michiel G. H. Betjes
Publikováno v:
European Journal of Gastroenterology & Hepatology, 31(11), 1444-1451. Lippincott Williams & Wilkins
BACKGROUND: Treatment with immunosuppressive drugs (IS) after transplantation is accompanied by severe side effects. A limited number of studies have investigated the effect of IS withdrawal on IS-related comorbidities after liver transplantation (LT
Autor:
Aafke A, Duizendstra, Robert J, de Knegt, Shanta, Mancham, Mariska, Klepper, Dave L, Roelen, Simone H, Brand-Schaaf, Patrick P, Boor, Michail, Doukas, Robert A, de Man, Dave, Sprengers, Maikel P, Peppelenbosch, Michiel G H, Betjes, Jaap, Kwekkeboom, Nicolle H R, Litjens
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 28(1)
Spontaneous operational tolerance to the allograft develops in a proportion of liver transplantation (LT) recipients weaned off immunosuppressive (IS) drugs. Several studies have investigated whether peripheral blood circulating T cells could play a
Autor:
Michail Doukas, Jaap Kwekkeboom, Nicolle H.R. Litjens, Thierry P P van den Bosch, Michiel G. H. Betjes, Aafke A. Duizendstra, Sarwa Darwish Murad, Dave Sprengers
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology, 45(3):101539. Elsevier Masson
Background Despite immunosuppressive drug regimens, T cell-mediated rejection, antibody-mediated rejection with donor-specific antibodies, and chronic rejection occur after liver transplantation (LTx). Rejection may significantly impact allograft sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cc754ab7c8440d8db230a08c42d2298
https://pure.eur.nl/en/publications/79aa0ed9-0083-4e5e-bfd6-4deb23b9a131
https://pure.eur.nl/en/publications/79aa0ed9-0083-4e5e-bfd6-4deb23b9a131
Autor:
Duizendstra, Aafke A., van der Grift, Michelle V., Boor, Patrick P., Noordam, Lisanne, de Knegt, Robert J., Peppelenbosch, Maikel P., Betjes, Michiel G. H., Litjens, Nicolle H. R., Kwekkeboom, Jaap
Publikováno v:
Frontiers in Immunology; 1/11/2022, Vol. 12, p1-10, 11p